Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06876896 · ClinicalTrials.gov registry record · NA
Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter
A NA study of Intra-Abdominal Hypertension, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06876896 is a NA study of Intra-Abdominal Hypertension that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06876896, a NA study of Intra-Abdominal Hypertension, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the intra-abdominal pressure utilizing the Accuryn monitoring system during pulsed field ablation procedures in the electrophysiology lab compared to the type of anesthetic utilized.
Conditions Studied
Interventions
- DEVICE Accuryn Foley catheter device
Study Locations (1)
North Carolina
- Wake Forest Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-03-03 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06876896
The ClinicalTrials.gov registry entry for NCT06876896 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intra-Abdominal Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Accuryn Foley catheter device is the first listed.
NCT06876896 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06876896 about?
NCT06876896 is a clinical study titled "Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter". The purpose of this study is to investigate the intra-abdominal pressure utilizing the Accuryn monitoring system during pulsed field ablation procedures in the electrophysiology lab compared to the type of anesthetic utilized.
What is the current status of trial NCT06876896?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-03-03. Estimated completion is 2026-12-30.
What conditions does trial NCT06876896 study?
This clinical trial studies the following conditions: Intra-Abdominal Hypertension.
What interventions are being tested in trial NCT06876896?
The interventions under investigation include: Accuryn Foley catheter device (DEVICE).
Who is sponsoring clinical trial NCT06876896?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06876896 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intra-Abdominal Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.